Metabolic Syndrome Effects over Heart Tissue: A Histomorphological Glance under the Light of p97/VCP and SVIP
- 15 September 2026
- journal article
- Published by Ordu University in Black Sea Journal of Health Science
- Vol. 9 (5) , 176-185
Abstract
Metabolic syndrome(MetS) is a cluster of metabolic disorders that significantly increases the risk of heart disease and type 2 diabetes. p97/VCP (Valosin-Containing Protein), is an ATPase enzyme that regulates many vital processes in the cell such as cell cycle control, apoptosis, protein degradation, and cellular stress. Small VCP-interacting protein (SVIP) has various important functions in the cell which are particularly in the endoplasmic reticulum and proteasome systems. SVIP is a small but effective regulator of the protein recycling and quality control system in the cell. It affects processes such as cellular stress response, protein accumulation, and degradation, particularly through its interaction with the p97/VCP protein. MetS is one of the most important risk factors for cardiovascular diseases. However, the roles of p97/VCP and SVIP in cardiac tissue affected by MetS remain unclear. Therefore, this study aimed to investigate the histomorphological changes and the expression levels of p97/VCP and SVIP in rat heart tissue in a MetS model. The histomorphological alterations in heart tissues were evaluated using Hematoxylin-Eosin and Weigert Van Gieson staining methods. Using the immunohistochemical technique, the expression of p97/VCP and SVIP in rat heart tissue were examined. Statistical analyses were conducted and pKeywords
This publication has 24 references indexed in Scilit:
- Valosin-containing protein: A potential therapeutic target for cardiovascular diseasesAgeing Research Reviews, 2024
- Valosin-Containing Protein (VCP)/p97 Oligomerization2024
- Effect of pioglitazone on the expression of ubiquitin proteasome system and autophagic proteins in rat pancreas with metabolic syndromeJournal of Molecular Histology, 2021
- Genomic characterization reveals novel mechanisms underlying the valosin-containing protein-mediated cardiac protection against heart failureRedox Biology, 2020
- Pioglitazone provides beneficial effect in metabolic syndrome rats via affecting intracellular Na+ DyshomeostasisJournal of Bioenergetics and Biomembranes, 2018
- Altered expression of p97/Valosin containing protein and impaired autophagy in preeclamptic human placentaPlacenta, 2018
- VCP/p97-Mediated Unfolding as a Principle in Protein Homeostasis and SignalingMolecular Cell, 2018
- Slowing Progress in Cardiovascular Mortality RatesJAMA Cardiology, 2016
- Role of autophagy in metabolic syndrome-associated heart diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2015
- Targeted deletion of p97 (VCP/CDC48) in mouse results in early embryonic lethalityBiochemical and Biophysical Research Communications, 2007